Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Up 31.9% in April

Takara Bio Inc. (OTCMKTS:TKBIFGet Free Report) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 69,100 shares, an increase of 31.9% from the March 31st total of 52,400 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Takara Bio Stock Performance

OTCMKTS:TKBIF remained flat at $23.20 during trading hours on Friday. Takara Bio has a 52 week low of $23.20 and a 52 week high of $23.20. The firm has a fifty day moving average price of $23.20 and a 200 day moving average price of $23.20.

About Takara Bio

(Get Free Report)

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.

Featured Articles

Receive News & Ratings for Takara Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takara Bio and related companies with MarketBeat.com's FREE daily email newsletter.